Local Manufacturing Requirements for IMPs in Chinese Clinical Trials
Local Manufacturing Requirements for IMPs in Chinese Clinical Trials Local Manufacturing Obligations for Investigational Medicinal Products in China Introduction Investigational Medicinal Products (IMPs) are the cornerstone of clinical trials, requiring rigorous controls to ensure safety, quality, and compliance. In China, sponsors must navigate specific local manufacturing requirements governed by the National Medical Products Administration (NMPA)….
Read More “Local Manufacturing Requirements for IMPs in Chinese Clinical Trials” »